According to one study, the FGF23 plasma level is unchanged in prostate cancer (Vlot et al., 2018), although prostate cancer cells may stimulate FGF23 expression in osteocytes (Choudhary et al., 2018). The gene discussed is FGF23; the disease is prostate carcinoma.